In the case of the three TBC1Ds herein characterized (TBC1D22B, TBC1D31 and TBC1D7), the mechanisms through which they sustain enhanced glycolytic metabolism in BC, and in TNBC in particular, remain to be elucidated. This evidence concerns the gene TBC1D31 and breast cancer.